文献速递肝病

戊型肝炎病毒感染:不止于肝脏?

Hepatitis E virus: Infection beyond the liver?
PubMed 文献 · J Hepatol · 2016-11-29

戊型肝炎病毒(HEV)感染不仅限于肝脏,还可能影响其他器官。综述汇总了格林-巴利综合征、神经痛性肌萎缩、肾小球肾炎、冷球蛋白血症、胰腺炎、淋巴瘤、血小板减少、脑膜炎、甲状腺炎和心肌炎等肝外表现,基于血清学、病例系列、体外数据和动物模型提示HEV可能为病因,但确切的病理生理联系尚未确立。利巴韦林和类固醇已在少量肝外表现患者中使用,疗效仍需大型多中心研究验证。

要点

  • HEV感染可伴肝外表现,包括神经、肾脏、血液、内分泌及心脏等系统疾病。
  • 神经元和肾脏疾病及胰腺炎似乎由HEV引起,其他疾病与HEV的因果关系更可疑。
  • 利巴韦林和类固醇曾用于少量HEV肝外表现患者,疗效需大型多中心研究验证。

核心结论

  • HEV感染可能累及肝脏以外器官,但HEV与肝外表现之间确切的病理生理联系尚未确立。
  • 基于血清学、病例系列、体外数据和动物模型,HEV感染可能是肝外表现的原因。
  • 神经元和肾脏疾病以及胰腺炎似乎由HEV引起,而HEV与其他疾病的因果关系更可疑。

研究设计与样本

  • 本文为综述,全面回顾了已发表的关于HEV与肝外表现的文献。

主要发现

  • 在戊型肝炎背景下观察到格林-巴利综合征、神经痛性肌萎缩、肾小球肾炎、冷球蛋白血症、胰腺炎、淋巴瘤、血小板减少、脑膜炎、甲状腺炎和心肌炎等疾病。
  • HEV相关肝外表现的可能来源包括肝外复制的直接细胞病变性组织损伤,或由过度宿主免疫反应诱导的免疫学过程。

临床怎么用

  • 肝病科医生应意识到急性或慢性HEV感染患者可能发生肝外表现。
  • 神经科、肾科、风湿科及其他专科医生在观察到本综述所述疾病时,应将HEV感染作为潜在鉴别诊断。
  • 利巴韦林和类固醇已在少量HEV肝外表现患者中使用,但其疗效仍需大型多中心研究验证。

局限性

  • HEV与肝外表现之间确切的病理生理联系尚未确立。
  • HEV与其他疾病的因果关系更可疑。
  • 利巴韦林和类固醇的疗效仍需大型多中心研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatitis E virus (HEV) infections are not limited to the liver but may also affect other organs. Several diseases, including Guillain-Barré syndrome, neuralgic amyotrophy, glomerulonephritis, cryoglobulinemia, pancreatitis, lymphoma, thrombopenia, meningitis, thyroiditis and myocarditis have been observed in the context of hepatitis E. To date, the definite pathophysiological links between HEV and extrahepatic manifestations are not yet established. However, it is suggested that HEV infection might be causative based on serological studies, case series, in vitro data and animal models. In particular, neuronal and renal diseases as well as pancreatitis seem to be caused by HEV, while a causative relationship between HEV and other diseases is more doubtful. Either direct cytopathic tissue damage by extrahepatic replication, or immunological processes induced by an overwhelming host immune response, are possible origins of HEV-associated extrahepatic manifestations. Hepatologists should be aware of the possibility that acute or chronically HEV-infected patients could develop extrahepatic manifestations. Neurologists, nephrologists, rheumatologists and other groups of physicians should consider HEV infection as a potential differential diagnosis when observing one of the diseases described in this review. Ribavirin and steroids have been used in small groups of patients with extrahepatic manifestations of HEV, but the efficacy of these drugs still needs to be verified by large, multicenter studies. This article comprehensively reviews the published literature regarding HEV and extrahepatic manifestations. We discuss the probability of specific extrahepatic diseases being caused by previous or ongoing HEV infection, and summarize the published knowledge about antiviral treatment in extrahepatic disorders.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Pischke S, Hartl J, Pas SD, et al. Hepatitis E virus: Infection beyond the liver? J Hepatol. 2016. PMID: 27913223. doi:10.1016/j.jhep.2016.11.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。